BIO-RAD LABORATORIES, INC. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2026-02-13: Form 10-K; Item Shares outstanding CommonClassA as of 2026-02-09; As filed 21,924,284.
- 2026-02-13: Form 10-K; Item Shares outstanding CommonClassB as of 2026-02-09; As filed 5,066,110.
- 2026-02-13: Form 10-K; Item Stock registered under Section 12(b); As filed Class B Common Stock Par Value $0.0001 per share · BIO.B · NYSE.
- 2025-02-14: Form 10-K; Item Shares outstanding CommonClassA as of 2025-02-11; As filed 22,940,805.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2026-02-13 | 10-K | Shares outstanding CommonClassA as of 2026-02-09 | 21,924,284 |
| 2026-02-13 | 10-K | Shares outstanding CommonClassB as of 2026-02-09 | 5,066,110 |
| 2026-02-13 | 10-K | Stock registered under Section 12(b) | Class B Common Stock Par Value $0.0001 per share · BIO.B · NYSE |
| 2025-02-14 | 10-K | Shares outstanding CommonClassA as of 2025-02-11 | 22,940,805 |
| 2025-02-14 | 10-K | Shares outstanding CommonClassB as of 2025-02-11 | 5,070,337 |
| 2025-02-14 | 10-K | Stock registered under Section 12(b) | Class B Common Stock Par Value $0.0001 per share · BIO.B · NYSE |
| 2024-02-16 | 10-K | Shares outstanding CommonClassA as of 2024-02-13 | 23,422,506 |
| 2024-02-16 | 10-K | Shares outstanding CommonClassB as of 2024-02-13 | 5,095,930 |
| 2024-02-16 | 10-K | Stock registered under Section 12(b) | Class B Common Stock Par Value $0.0001 per share · BIO.B · NYSE |
| 2023-02-17 | 10-K | Shares outstanding CommonClassA as of 2023-02-14 | 24,521,581 |
| 2023-02-17 | 10-K | Shares outstanding CommonClassB as of 2023-02-14 | 5,074,130 |
| 2023-02-17 | 10-K | Stock registered under Section 12(b) | Class B Common Stock Par Value $0.0001 per share · BIOb · NYSE |
| 2022-02-11 | 10-K | Shares outstanding CommonClassA as of 2022-02-09 | 24,860,701 |
| 2022-02-11 | 10-K | Shares outstanding CommonClassB as of 2022-02-09 | 5,071,736 |
| 2022-02-11 | 10-K | Stock registered under Section 12(b) | Class B Common Stock Par Value $0.0001 per share · BIOb · NYSE |
| 2021-02-16 | 10-K | Shares outstanding CommonClassA as of 2021-02-10 | 24,768,670 |
| 2021-02-16 | 10-K | Shares outstanding CommonClassB as of 2021-02-10 | 5,075,386 |
| 2021-02-16 | 10-K | Stock registered under Section 12(b) | Class B Common Stock Par Value $0.0001 per share · BIOb · NYSE |
| 2021-02-16 | 10-K | Well-known seasoned issuer | No |
| 2020-03-02 | 10-K | Shares outstanding CommonClassA as of 2020-02-24 | 24,839,715 |
| 2020-03-02 | 10-K | Shares outstanding CommonClassB as of 2020-02-24 | 5,085,621 |
| 2020-03-02 | 10-K | Stock registered under Section 12(b) | Class B Common Stock Par Value $0.0001 per share · BIOb · NYSE |
| 2020-03-02 | 10-K | Well-known seasoned issuer | No |
| 2019-04-01 | 10-K | Shares outstanding CommonClassA as of 2019-03-26 | 24,707,868 |
| 2019-04-01 | 10-K | Shares outstanding CommonClassB as of 2019-03-26 | 5,092,404 |
| 2019-04-01 | 10-K | Well-known seasoned issuer | No |
| 2018-04-16 | 10-K | Shares outstanding CommonClassA as of 2018-04-10 | 24,701,407 |
| 2018-04-16 | 10-K | Shares outstanding CommonClassB as of 2018-04-10 | 5,103,283 |
| 2018-04-16 | 10-K | Well-known seasoned issuer | No |
| 2017-03-01 | 10-K | Shares outstanding CommonClassA as of 2017-02-14 | 24,460,068 |
| 2017-03-01 | 10-K | Shares outstanding CommonClassB as of 2017-02-14 | 5,116,824 |